Global Nonalcoholic Steatohepatitis (NASH) Sales Market Report 2018

非アルコール性脂肪性肝炎(NASH)の世界市場:販売動向2018

◆タイトル:Global Nonalcoholic Steatohepatitis (NASH) Sales Market Report 2018
◆商品コード:QYR80709418
◆調査・発行会社:QYResearch
◆発行日:2018年10月
◆ページ数:116
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、世界主要国(日本、アメリカ、中国、ヨーロッパ等)
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD8,000 ⇒換算¥904,000見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

本調査レポートでは、非アルコール性脂肪性肝炎(NASH)の世界市場について調査・分析し、非アルコール性脂肪性肝炎(NASH)のメーカー別販売量、市場シェア分析、種類別販売分析(減量治療、インスリン感受性薬剤、脂質低下薬、抗酸化物質、その他)、用途別販売分析(病院、診療所、研究機関、その他)、地域別販売分析(米国、中国、欧州、日本、東南アジア、インド)、価格動向、企業動向、非アルコール性脂肪性肝炎(NASH)産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。

・非アルコール性脂肪性肝炎(NASH)市場概要
・非アルコール性脂肪性肝炎(NASH)のメーカー別販売量・メーカー別シェア
・非アルコール性脂肪性肝炎(NASH)の世界市場:種類別販売量(減量治療、インスリン感受性薬剤、脂質低下薬、抗酸化物質、その他)
・非アルコール性脂肪性肝炎(NASH)の世界市場:用途別販売量(病院、診療所、研究機関、その他)
・非アルコール性脂肪性肝炎(NASH)の世界市場:地域別販売量・市場シェア
・非アルコール性脂肪性肝炎(NASH)の米国市場規模
・非アルコール性脂肪性肝炎(NASH)の中国市場規模
・非アルコール性脂肪性肝炎(NASH)の欧州市場規模
・非アルコール性脂肪性肝炎(NASH)の日本市場規模
・非アルコール性脂肪性肝炎(NASH)の東南アジア市場規模
・非アルコール性脂肪性肝炎(NASH)のインド市場規模
・非アルコール性脂肪性肝炎(NASH)のメーカー別分析(企業概要、事業概要、製品概要、収益、価格等)
・非アルコール性脂肪性肝炎(NASH)のコスト分析・価格動向
・非アルコール性脂肪性肝炎(NASH)の産業チェーン(サプライチェーン分析)
・非アルコール性脂肪性肝炎(NASH)のマーケティング戦略・販売チャネル、流通業者
・非アルコール性脂肪性肝炎(NASH)市場への影響要因分析
・非アルコール性脂肪性肝炎(NASH)の世界市場予測
・非アルコール性脂肪性肝炎(NASH)の米国市場予測
・非アルコール性脂肪性肝炎(NASH)の中国市場予測
・非アルコール性脂肪性肝炎(NASH)の欧州市場予測
・非アルコール性脂肪性肝炎(NASH)の日本市場予測
・非アルコール性脂肪性肝炎(NASH)の東南アジア市場予測
・非アルコール性脂肪性肝炎(NASH)のインド市場予測
・非アルコール性脂肪性肝炎(NASH)の種類別世界市場予測(減量治療、インスリン感受性薬剤、脂質低下薬、抗酸化物質、その他)
・非アルコール性脂肪性肝炎(NASH)の用途別世界市場予測(病院、診療所、研究機関、その他)
...

This report studies the global Nonalcoholic Steatohepatitis (NASH) market status and forecast, categorizes the global Nonalcoholic Steatohepatitis (NASH) market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).
The global Nonalcoholic Steatohepatitis (NASH) market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025.

The major players covered in this report
Boehringer Ingelheim
Cerenis Therapeutics
Connexios Life Sciences
Genfit
Islet Sciences
Nimbus Therapeutics
Verva Pharmaceuticals
Viking Therapeutics
Astazeneca Plc
Galmed Pharmaceuticals
GENFIT SA
Gilead Science
Novo Nordisk
Immuron
Intercepts Pharmaceuticals
Enzo Biochem
Tobira Therapeutics

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
United States
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Weight Loss Treatment
Insulin-Sensitizing Agents
Lipid-Lowering Drugs
Antioxidants
Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Hospitals
Clinics
Research Institute
Other

The study objectives of this report are:
To analyze and study the global Nonalcoholic Steatohepatitis (NASH) sales, value, status (2013-2017) and forecast (2018-2025);
To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
Focuses on the key Nonalcoholic Steatohepatitis (NASH) players, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Nonalcoholic Steatohepatitis (NASH) are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Nonalcoholic Steatohepatitis (NASH) Manufacturers
Nonalcoholic Steatohepatitis (NASH) Distributors/Traders/Wholesalers
Nonalcoholic Steatohepatitis (NASH) Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company’s specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Nonalcoholic Steatohepatitis (NASH) market, by end-use.
Detailed analysis and profiles of additional market players.

【レポートの目次】

Table of Contents

Global Nonalcoholic Steatohepatitis (NASH) Sales Market Report 2018
1 Nonalcoholic Steatohepatitis (NASH) Market Overview
1.1 Product Overview and Scope of Nonalcoholic Steatohepatitis (NASH)
1.2 Classification of Nonalcoholic Steatohepatitis (NASH) by Product Category
1.2.1 Global Nonalcoholic Steatohepatitis (NASH) Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 Global Nonalcoholic Steatohepatitis (NASH) Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 Weight Loss Treatment
1.2.4 Insulin-Sensitizing Agents
1.2.5 Lipid-Lowering Drugs
1.2.6 Antioxidants
1.2.7 Other
1.3 Global Nonalcoholic Steatohepatitis (NASH) Market by Application/End Users
1.3.1 Global Nonalcoholic Steatohepatitis (NASH) Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.1 Hospitals
1.3.2 Clinics
1.3.3 Research Institute
1.3.4 Other
1.4 Global Nonalcoholic Steatohepatitis (NASH) Market by Region
1.4.1 Global Nonalcoholic Steatohepatitis (NASH) Market Size (Value) Comparison by Region (2013-2025)
1.4.2 United States Nonalcoholic Steatohepatitis (NASH) Status and Prospect (2013-2025)
1.4.3 Europe Nonalcoholic Steatohepatitis (NASH) Status and Prospect (2013-2025)
1.4.4 China Nonalcoholic Steatohepatitis (NASH) Status and Prospect (2013-2025)
1.4.5 Japan Nonalcoholic Steatohepatitis (NASH) Status and Prospect (2013-2025)
1.4.6 Southeast Asia Nonalcoholic Steatohepatitis (NASH) Status and Prospect (2013-2025)
1.4.7 India Nonalcoholic Steatohepatitis (NASH) Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Nonalcoholic Steatohepatitis (NASH) (2013-2025)
1.5.1 Global Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2013-2025)
1.5.2 Global Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2025)

2 Global Nonalcoholic Steatohepatitis (NASH) Competition by Players/Suppliers, Type and Application
2.1 Global Nonalcoholic Steatohepatitis (NASH) Market Competition by Players/Suppliers
2.1.1 Global Nonalcoholic Steatohepatitis (NASH) Sales and Market Share of Key Players/Suppliers (2013-2018)
2.1.2 Global Nonalcoholic Steatohepatitis (NASH) Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Nonalcoholic Steatohepatitis (NASH) (Volume and Value) by Type
2.2.1 Global Nonalcoholic Steatohepatitis (NASH) Sales and Market Share by Type (2013-2018)
2.2.2 Global Nonalcoholic Steatohepatitis (NASH) Revenue and Market Share by Type (2013-2018)
2.3 Global Nonalcoholic Steatohepatitis (NASH) (Volume and Value) by Region
2.3.1 Global Nonalcoholic Steatohepatitis (NASH) Sales and Market Share by Region (2013-2018)
2.3.2 Global Nonalcoholic Steatohepatitis (NASH) Revenue and Market Share by Region (2013-2018)
2.4 Global Nonalcoholic Steatohepatitis (NASH) (Volume) by Application

3 United States Nonalcoholic Steatohepatitis (NASH) (Volume, Value and Sales Price)
3.1 United States Nonalcoholic Steatohepatitis (NASH) Sales and Value (2013-2018)
3.1.1 United States Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2013-2018)
3.1.2 United States Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)
3.1.3 United States Nonalcoholic Steatohepatitis (NASH) Sales Price Trend (2013-2018)
3.2 United States Nonalcoholic Steatohepatitis (NASH) Sales Volume and Market Share by Players (2013-2018)
3.3 United States Nonalcoholic Steatohepatitis (NASH) Sales Volume and Market Share by Type (2013-2018)
3.4 United States Nonalcoholic Steatohepatitis (NASH) Sales Volume and Market Share by Application (2013-2018)

4 Europe Nonalcoholic Steatohepatitis (NASH) (Volume, Value and Sales Price)
4.1 Europe Nonalcoholic Steatohepatitis (NASH) Sales and Value (2013-2018)
4.1.1 Europe Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2013-2018)
4.1.2 Europe Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)
4.1.3 Europe Nonalcoholic Steatohepatitis (NASH) Sales Price Trend (2013-2018)
4.2 Europe Nonalcoholic Steatohepatitis (NASH) Sales Volume and Market Share by Players (2013-2018)
4.3 Europe Nonalcoholic Steatohepatitis (NASH) Sales Volume and Market Share by Type (2013-2018)
4.4 Europe Nonalcoholic Steatohepatitis (NASH) Sales Volume and Market Share by Application (2013-2018)

5 China Nonalcoholic Steatohepatitis (NASH) (Volume, Value and Sales Price)
5.1 China Nonalcoholic Steatohepatitis (NASH) Sales and Value (2013-2018)
5.1.1 China Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2013-2018)
5.1.2 China Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)
5.1.3 China Nonalcoholic Steatohepatitis (NASH) Sales Price Trend (2013-2018)
5.2 China Nonalcoholic Steatohepatitis (NASH) Sales Volume and Market Share by Players (2013-2018)
5.3 China Nonalcoholic Steatohepatitis (NASH) Sales Volume and Market Share by Type (2013-2018)
5.4 China Nonalcoholic Steatohepatitis (NASH) Sales Volume and Market Share by Application (2013-2018)

6 Japan Nonalcoholic Steatohepatitis (NASH) (Volume, Value and Sales Price)
6.1 Japan Nonalcoholic Steatohepatitis (NASH) Sales and Value (2013-2018)
6.1.1 Japan Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2013-2018)
6.1.2 Japan Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)
6.1.3 Japan Nonalcoholic Steatohepatitis (NASH) Sales Price Trend (2013-2018)
6.2 Japan Nonalcoholic Steatohepatitis (NASH) Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Nonalcoholic Steatohepatitis (NASH) Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Nonalcoholic Steatohepatitis (NASH) Sales Volume and Market Share by Application (2013-2018)

7 Southeast Asia Nonalcoholic Steatohepatitis (NASH) (Volume, Value and Sales Price)
7.1 Southeast Asia Nonalcoholic Steatohepatitis (NASH) Sales and Value (2013-2018)
7.1.1 Southeast Asia Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2013-2018)
7.1.2 Southeast Asia Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)
7.1.3 Southeast Asia Nonalcoholic Steatohepatitis (NASH) Sales Price Trend (2013-2018)
7.2 Southeast Asia Nonalcoholic Steatohepatitis (NASH) Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Nonalcoholic Steatohepatitis (NASH) Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Nonalcoholic Steatohepatitis (NASH) Sales Volume and Market Share by Application (2013-2018)

8 India Nonalcoholic Steatohepatitis (NASH) (Volume, Value and Sales Price)
8.1 India Nonalcoholic Steatohepatitis (NASH) Sales and Value (2013-2018)
8.1.1 India Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2013-2018)
8.1.2 India Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)
8.1.3 India Nonalcoholic Steatohepatitis (NASH) Sales Price Trend (2013-2018)
8.2 India Nonalcoholic Steatohepatitis (NASH) Sales Volume and Market Share by Players (2013-2018)
8.3 India Nonalcoholic Steatohepatitis (NASH) Sales Volume and Market Share by Type (2013-2018)
8.4 India Nonalcoholic Steatohepatitis (NASH) Sales Volume and Market Share by Application (2013-2018)

9 Global Nonalcoholic Steatohepatitis (NASH) Players/Suppliers Profiles and Sales Data
9.1 Boehringer Ingelheim
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Nonalcoholic Steatohepatitis (NASH) Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Boehringer Ingelheim Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2013-2018)
9.1.4 Main Business/Business Overview
9.2 Cerenis Therapeutics
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Nonalcoholic Steatohepatitis (NASH) Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Cerenis Therapeutics Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2013-2018)
9.2.4 Main Business/Business Overview
9.3 Connexios Life Sciences
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Nonalcoholic Steatohepatitis (NASH) Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Connexios Life Sciences Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2013-2018)
9.3.4 Main Business/Business Overview
9.4 Genfit
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Nonalcoholic Steatohepatitis (NASH) Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Genfit Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2013-2018)
9.4.4 Main Business/Business Overview
9.5 Islet Sciences
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Nonalcoholic Steatohepatitis (NASH) Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Islet Sciences Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2013-2018)
9.5.4 Main Business/Business Overview
9.6 Nimbus Therapeutics
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Nonalcoholic Steatohepatitis (NASH) Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Nimbus Therapeutics Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2013-2018)
9.6.4 Main Business/Business Overview
9.7 Verva Pharmaceuticals
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Nonalcoholic Steatohepatitis (NASH) Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Verva Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2013-2018)
9.7.4 Main Business/Business Overview
9.8 Viking Therapeutics
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Nonalcoholic Steatohepatitis (NASH) Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Viking Therapeutics Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2013-2018)
9.8.4 Main Business/Business Overview
9.9 Astazeneca Plc
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Nonalcoholic Steatohepatitis (NASH) Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Astazeneca Plc Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2013-2018)
9.9.4 Main Business/Business Overview
9.10 Galmed Pharmaceuticals
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Nonalcoholic Steatohepatitis (NASH) Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2013-2018)
9.10.4 Main Business/Business Overview
9.11 GENFIT SA
9.12 Gilead Science
9.13 Novo Nordisk
9.14 Immuron
9.15 Intercepts Pharmaceuticals
9.16 Enzo Biochem
9.17 Tobira Therapeutics

10 Nonalcoholic Steatohepatitis (NASH) Maufacturing Cost Analysis
10.1 Nonalcoholic Steatohepatitis (NASH) Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Nonalcoholic Steatohepatitis (NASH)
10.3 Manufacturing Process Analysis of Nonalcoholic Steatohepatitis (NASH)

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Nonalcoholic Steatohepatitis (NASH) Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Nonalcoholic Steatohepatitis (NASH) Major Manufacturers in 2017
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Nonalcoholic Steatohepatitis (NASH) Market Forecast (2018-2025)
14.1 Global Nonalcoholic Steatohepatitis (NASH) Sales Volume, Revenue and Price Forecast (2018-2025)
14.1.1 Global Nonalcoholic Steatohepatitis (NASH) Sales Volume and Growth Rate Forecast (2018-2025)
14.1.2 Global Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate Forecast (2018-2025)
14.1.3 Global Nonalcoholic Steatohepatitis (NASH) Price and Trend Forecast (2018-2025)
14.2 Global Nonalcoholic Steatohepatitis (NASH) Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
14.2.1 Global Nonalcoholic Steatohepatitis (NASH) Sales Volume and Growth Rate Forecast by Regions (2018-2025)
14.2.2 Global Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate Forecast by Regions (2018-2025)
14.2.3 United States Nonalcoholic Steatohepatitis (NASH) Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.4 Europe Nonalcoholic Steatohepatitis (NASH) Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.5 China Nonalcoholic Steatohepatitis (NASH) Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.6 Japan Nonalcoholic Steatohepatitis (NASH) Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.7 Southeast Asia Nonalcoholic Steatohepatitis (NASH) Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.8 India Nonalcoholic Steatohepatitis (NASH) Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Nonalcoholic Steatohepatitis (NASH) Sales Volume, Revenue and Price Forecast by Type (2018-2025)
14.3.1 Global Nonalcoholic Steatohepatitis (NASH) Sales Forecast by Type (2018-2025)
14.3.2 Global Nonalcoholic Steatohepatitis (NASH) Revenue Forecast by Type (2018-2025)
14.3.3 Global Nonalcoholic Steatohepatitis (NASH) Price Forecast by Type (2018-2025)
14.4 Global Nonalcoholic Steatohepatitis (NASH) Sales Volume Forecast by Application (2018-2025)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Nonalcoholic Steatohepatitis (NASH)
Figure Global Nonalcoholic Steatohepatitis (NASH) Sales Volume Comparison (K Pcs) by Type (2013-2025)
Figure Global Nonalcoholic Steatohepatitis (NASH) Sales Volume Market Share by Type (Product Category) in 2017
Figure Weight Loss Treatment Product Picture
Figure Insulin-Sensitizing Agents Product Picture
Figure Lipid-Lowering Drugs Product Picture
Figure Antioxidants Product Picture
Figure Other Product Picture
Figure Global Nonalcoholic Steatohepatitis (NASH) Sales Comparison (K Pcs) by Application (2013-2025)
Figure Global Sales Market Share of Nonalcoholic Steatohepatitis (NASH) by Application in 2017
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Clinics Examples
Table Key Downstream Customer in Clinics
Figure Research Institute Examples
Table Key Downstream Customer in Research Institute
Figure Other Examples
Table Key Downstream Customer in Other
Figure Global Nonalcoholic Steatohepatitis (NASH) Market Size (Million USD) by Regions (2013-2025)
Figure United States Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Nonalcoholic Steatohepatitis (NASH) Sales Volume (K Pcs) and Growth Rate (2013-2025)
Figure Global Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players Nonalcoholic Steatohepatitis (NASH) Sales Volume (K Pcs) (2013-2018)
Table Global Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table Global Nonalcoholic Steatohepatitis (NASH) Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Nonalcoholic Steatohepatitis (NASH) Sales Share by Players/Suppliers
Figure 2017 Nonalcoholic Steatohepatitis (NASH) Sales Share by Players/Suppliers
Figure Global Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Nonalcoholic Steatohepatitis (NASH) Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global Nonalcoholic Steatohepatitis (NASH) Revenue Share by Players
Table 2017 Global Nonalcoholic Steatohepatitis (NASH) Revenue Share by Players
Table Global Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) and Market Share by Type (2013-2018)
Table Global Nonalcoholic Steatohepatitis (NASH) Sales Share (K Pcs) by Type (2013-2018)
Figure Sales Market Share of Nonalcoholic Steatohepatitis (NASH) by Type (2013-2018)
Figure Global Nonalcoholic Steatohepatitis (NASH) Sales Growth Rate by Type (2013-2018)
Table Global Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global Nonalcoholic Steatohepatitis (NASH) Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Nonalcoholic Steatohepatitis (NASH) by Type (2013-2018)
Figure Global Nonalcoholic Steatohepatitis (NASH) Revenue Growth Rate by Type (2013-2018)
Table Global Nonalcoholic Steatohepatitis (NASH) Sales Volume (K Pcs) and Market Share by Region (2013-2018)
Table Global Nonalcoholic Steatohepatitis (NASH) Sales Share by Region (2013-2018)
Figure Sales Market Share of Nonalcoholic Steatohepatitis (NASH) by Region (2013-2018)
Figure Global Nonalcoholic Steatohepatitis (NASH) Sales Growth Rate by Region in 2017
Table Global Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Nonalcoholic Steatohepatitis (NASH) Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Nonalcoholic Steatohepatitis (NASH) by Region (2013-2018)
Figure Global Nonalcoholic Steatohepatitis (NASH) Revenue Growth Rate by Region in 2017
Table Global Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Nonalcoholic Steatohepatitis (NASH) Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Nonalcoholic Steatohepatitis (NASH) by Region (2013-2018)
Figure Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Region in 2017
Table Global Nonalcoholic Steatohepatitis (NASH) Sales Volume (K Pcs) and Market Share by Application (2013-2018)
Table Global Nonalcoholic Steatohepatitis (NASH) Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of Nonalcoholic Steatohepatitis (NASH) by Application (2013-2018)
Figure Global Nonalcoholic Steatohepatitis (NASH) Sales Market Share by Application (2013-2018)
Figure United States Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) and Growth Rate (2013-2018)
Figure United States Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States Nonalcoholic Steatohepatitis (NASH) Sales Price (USD/Pcs) Trend (2013-2018)
Table United States Nonalcoholic Steatohepatitis (NASH) Sales Volume (K Pcs) by Players (2013-2018)
Table United States Nonalcoholic Steatohepatitis (NASH) Sales Volume Market Share by Players (2013-2018)
Figure United States Nonalcoholic Steatohepatitis (NASH) Sales Volume Market Share by Players in 2017
Table United States Nonalcoholic Steatohepatitis (NASH) Sales Volume (K Pcs) by Type (2013-2018)
Table United States Nonalcoholic Steatohepatitis (NASH) Sales Volume Market Share by Type (2013-2018)
Figure United States Nonalcoholic Steatohepatitis (NASH) Sales Volume Market Share by Type in 2017
Table United States Nonalcoholic Steatohepatitis (NASH) Sales Volume (K Pcs) by Application (2013-2018)
Table United States Nonalcoholic Steatohepatitis (NASH) Sales Volume Market Share by Application (2013-2018)
Figure United States Nonalcoholic Steatohepatitis (NASH) Sales Volume Market Share by Application in 2017
Figure Europe Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) and Growth Rate (2013-2018)
Figure Europe Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe Nonalcoholic Steatohepatitis (NASH) Sales Price (USD/Pcs) Trend (2013-2018)
Table Europe Nonalcoholic Steatohepatitis (NASH) Sales Volume (K Pcs) by Players (2013-2018)
Table Europe Nonalcoholic Steatohepatitis (NASH) Sales Volume Market Share by Players (2013-2018)
Figure Europe Nonalcoholic Steatohepatitis (NASH) Sales Volume Market Share by Players in 2017
Table Europe Nonalcoholic Steatohepatitis (NASH) Sales Volume (K Pcs) by Type (2013-2018)
Table Europe Nonalcoholic Steatohepatitis (NASH) Sales Volume Market Share by Type (2013-2018)
Figure Europe Nonalcoholic Steatohepatitis (NASH) Sales Volume Market Share by Type in 2017
Table Europe Nonalcoholic Steatohepatitis (NASH) Sales Volume (K Pcs) by Application (2013-2018)
Table Europe Nonalcoholic Steatohepatitis (NASH) Sales Volume Market Share by Application (2013-2018)
Figure Europe Nonalcoholic Steatohepatitis (NASH) Sales Volume Market Share by Application in 2017
Figure China Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) and Growth Rate (2013-2018)
Figure China Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Nonalcoholic Steatohepatitis (NASH) Sales Price (USD/Pcs) Trend (2013-2018)
Table China Nonalcoholic Steatohepatitis (NASH) Sales Volume (K Pcs) by Players (2013-2018)
Table China Nonalcoholic Steatohepatitis (NASH) Sales Volume Market Share by Players (2013-2018)
Figure China Nonalcoholic Steatohepatitis (NASH) Sales Volume Market Share by Players in 2017
Table China Nonalcoholic Steatohepatitis (NASH) Sales Volume (K Pcs) by Type (2013-2018)
Table China Nonalcoholic Steatohepatitis (NASH) Sales Volume Market Share by Type (2013-2018)
Figure China Nonalcoholic Steatohepatitis (NASH) Sales Volume Market Share by Type in 2017
Table China Nonalcoholic Steatohepatitis (NASH) Sales Volume (K Pcs) by Application (2013-2018)
Table China Nonalcoholic Steatohepatitis (NASH) Sales Volume Market Share by Application (2013-2018)
Figure China Nonalcoholic Steatohepatitis (NASH) Sales Volume Market Share by Application in 2017
Figure Japan Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) and Growth Rate (2013-2018)
Figure Japan Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Nonalcoholic Steatohepatitis (NASH) Sales Price (USD/Pcs) Trend (2013-2018)
Table Japan Nonalcoholic Steatohepatitis (NASH) Sales Volume (K Pcs) by Players (2013-2018)
Table Japan Nonalcoholic Steatohepatitis (NASH) Sales Volume Market Share by Players (2013-2018)
Figure Japan Nonalcoholic Steatohepatitis (NASH) Sales Volume Market Share by Players in 2017
Table Japan Nonalcoholic Steatohepatitis (NASH) Sales Volume (K Pcs) by Type (2013-2018)
Table Japan Nonalcoholic Steatohepatitis (NASH) Sales Volume Market Share by Type (2013-2018)
Figure Japan Nonalcoholic Steatohepatitis (NASH) Sales Volume Market Share by Type in 2017
Table Japan Nonalcoholic Steatohepatitis (NASH) Sales Volume (K Pcs) by Application (2013-2018)
Table Japan Nonalcoholic Steatohepatitis (NASH) Sales Volume Market Share by Application (2013-2018)
Figure Japan Nonalcoholic Steatohepatitis (NASH) Sales Volume Market Share by Application in 2017
Figure Southeast Asia Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) and Growth Rate (2013-2018)
Figure Southeast Asia Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Nonalcoholic Steatohepatitis (NASH) Sales Price (USD/Pcs) Trend (2013-2018)
Table Southeast Asia Nonalcoholic Steatohepatitis (NASH) Sales Volume (K Pcs) by Players (2013-2018)
Table Southeast Asia Nonalcoholic Steatohepatitis (NASH) Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia Nonalcoholic Steatohepatitis (NASH) Sales Volume Market Share by Players in 2017
Table Southeast Asia Nonalcoholic Steatohepatitis (NASH) Sales Volume (K Pcs) by Type (2013-2018)
Table Southeast Asia Nonalcoholic Steatohepatitis (NASH) Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Nonalcoholic Steatohepatitis (NASH) Sales Volume Market Share by Type in 2017
Table Southeast Asia Nonalcoholic Steatohepatitis (NASH) Sales Volume (K Pcs) by Application (2013-2018)
Table Southeast Asia Nonalcoholic Steatohepatitis (NASH) Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Nonalcoholic Steatohepatitis (NASH) Sales Volume Market Share by Application in 2017
Figure India Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) and Growth Rate (2013-2018)
Figure India Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Nonalcoholic Steatohepatitis (NASH) Sales Price (USD/Pcs) Trend (2013-2018)
Table India Nonalcoholic Steatohepatitis (NASH) Sales Volume (K Pcs) by Players (2013-2018)
Table India Nonalcoholic Steatohepatitis (NASH) Sales Volume Market Share by Players (2013-2018)
Figure India Nonalcoholic Steatohepatitis (NASH) Sales Volume Market Share by Players in 2017
Table India Nonalcoholic Steatohepatitis (NASH) Sales Volume (K Pcs) by Type (2013-2018)
Table India Nonalcoholic Steatohepatitis (NASH) Sales Volume Market Share by Type (2013-2018)
Figure India Nonalcoholic Steatohepatitis (NASH) Sales Volume Market Share by Type in 2017
Table India Nonalcoholic Steatohepatitis (NASH) Sales Volume (K Pcs) by Application (2013-2018)
Table India Nonalcoholic Steatohepatitis (NASH) Sales Volume Market Share by Application (2013-2018)
Figure India Nonalcoholic Steatohepatitis (NASH) Sales Volume Market Share by Application in 2017
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Boehringer Ingelheim Nonalcoholic Steatohepatitis (NASH) Sales Growth Rate (2013-2018)
Figure Boehringer Ingelheim Nonalcoholic Steatohepatitis (NASH) Sales Global Market Share (2013-2018)
Figure Boehringer Ingelheim Nonalcoholic Steatohepatitis (NASH) Revenue Global Market Share (2013-2018)
Table Cerenis Therapeutics Basic Information List
Table Cerenis Therapeutics Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Cerenis Therapeutics Nonalcoholic Steatohepatitis (NASH) Sales Growth Rate (2013-2018)
Figure Cerenis Therapeutics Nonalcoholic Steatohepatitis (NASH) Sales Global Market Share (2013-2018)
Figure Cerenis Therapeutics Nonalcoholic Steatohepatitis (NASH) Revenue Global Market Share (2013-2018)
Table Connexios Life Sciences Basic Information List
Table Connexios Life Sciences Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Connexios Life Sciences Nonalcoholic Steatohepatitis (NASH) Sales Growth Rate (2013-2018)
Figure Connexios Life Sciences Nonalcoholic Steatohepatitis (NASH) Sales Global Market Share (2013-2018
Figure Connexios Life Sciences Nonalcoholic Steatohepatitis (NASH) Revenue Global Market Share (2013-2018)
Table Genfit Basic Information List
Table Genfit Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Genfit Nonalcoholic Steatohepatitis (NASH) Sales Growth Rate (2013-2018)
Figure Genfit Nonalcoholic Steatohepatitis (NASH) Sales Global Market Share (2013-2018)
Figure Genfit Nonalcoholic Steatohepatitis (NASH) Revenue Global Market Share (2013-2018)
Table Islet Sciences Basic Information List
Table Islet Sciences Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Islet Sciences Nonalcoholic Steatohepatitis (NASH) Sales Growth Rate (2013-2018)
Figure Islet Sciences Nonalcoholic Steatohepatitis (NASH) Sales Global Market Share (2013-2018)
Figure Islet Sciences Nonalcoholic Steatohepatitis (NASH) Revenue Global Market Share (2013-2018)
Table Nimbus Therapeutics Basic Information List
Table Nimbus Therapeutics Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Nimbus Therapeutics Nonalcoholic Steatohepatitis (NASH) Sales Growth Rate (2013-2018)
Figure Nimbus Therapeutics Nonalcoholic Steatohepatitis (NASH) Sales Global Market Share (2013-2018
Figure Nimbus Therapeutics Nonalcoholic Steatohepatitis (NASH) Revenue Global Market Share (2013-2018)
Table Verva Pharmaceuticals Basic Information List
Table Verva Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Verva Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Sales Growth Rate (2013-2018)
Figure Verva Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Sales Global Market Share (2013-2018)
Figure Verva Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue Global Market Share (2013-2018)
Table Viking Therapeutics Basic Information List
Table Viking Therapeutics Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Viking Therapeutics Nonalcoholic Steatohepatitis (NASH) Sales Growth Rate (2013-2018)
Figure Viking Therapeutics Nonalcoholic Steatohepatitis (NASH) Sales Global Market Share (2013-2018
Figure Viking Therapeutics Nonalcoholic Steatohepatitis (NASH) Revenue Global Market Share (2013-2018)
Table Astazeneca Plc Basic Information List
Table Astazeneca Plc Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Astazeneca Plc Nonalcoholic Steatohepatitis (NASH) Sales Growth Rate (2013-2018)
Figure Astazeneca Plc Nonalcoholic Steatohepatitis (NASH) Sales Global Market Share (2013-2018)
Figure Astazeneca Plc Nonalcoholic Steatohepatitis (NASH) Revenue Global Market Share (2013-2018)
Table Galmed Pharmaceuticals Basic Information List
Table Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Sales Growth Rate (2013-2018)
Figure Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Sales Global Market Share (2013-2018)
Figure Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue Global Market Share (2013-2018)
Table GENFIT SA Basic Information List
Table Gilead Science Basic Information List
Table Novo Nordisk Basic Information List
Table Immuron Basic Information List
Table Intercepts Pharmaceuticals Basic Information List
Table Enzo Biochem Basic Information List
Table Tobira Therapeutics Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nonalcoholic Steatohepatitis (NASH)
Figure Manufacturing Process Analysis of Nonalcoholic Steatohepatitis (NASH)
Figure Nonalcoholic Steatohepatitis (NASH) Industrial Chain Analysis
Table Raw Materials Sources of Nonalcoholic Steatohepatitis (NASH) Major Players in 2017
Table Major Buyers of Nonalcoholic Steatohepatitis (NASH)
Table Distributors/Traders List
Figure Global Nonalcoholic Steatohepatitis (NASH) Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Global Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Nonalcoholic Steatohepatitis (NASH) Price (USD/Pcs) and Trend Forecast (2018-2025)
Table Global Nonalcoholic Steatohepatitis (NASH) Sales Volume (K Pcs) Forecast by Regions (2018-2025)
Figure Global Nonalcoholic Steatohepatitis (NASH) Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Nonalcoholic Steatohepatitis (NASH) Sales Volume Market Share Forecast by Regions in 2025
Table Global Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share Forecast by Regions in 2025
Figure United States Nonalcoholic Steatohepatitis (NASH) Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure United States Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Europe Nonalcoholic Steatohepatitis (NASH) Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Europe Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate Forecast (2018-2025)
Figure China Nonalcoholic Steatohepatitis (NASH) Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure China Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Nonalcoholic Steatohepatitis (NASH) Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Japan Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Nonalcoholic Steatohepatitis (NASH) Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Nonalcoholic Steatohepatitis (NASH) Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure India Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) Forecast by Type (2018-2025)
Figure Global Nonalcoholic Steatohepatitis (NASH) Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share Forecast by Type (2018-2025)
Table Global Nonalcoholic Steatohepatitis (NASH) Price (USD/Pcs) Forecast by Type (2018-2025)
Table Global Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) Forecast by Application (2018-2025)
Figure Global Nonalcoholic Steatohepatitis (NASH) Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【レポートのキーワード】

非アルコール性脂肪性肝炎(NASH)、減量治療、インスリン感受性薬剤、脂質低下薬、抗酸化物質、病院、診療所、研究機関

【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[非アルコール性脂肪性肝炎(NASH)の世界市場:販売動向2018] (Global Nonalcoholic Steatohepatitis (NASH) Sales Market Report 2018 / QYR80709418)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆